ARTICLES BY C. RAJAN

• Cubist's Anti-Bacterial Drug Sivextro Now Available in U.S.

  8/15/2014

  Cubist Pharmaceuticals announced last week that its anti-bacterial drug, Sivextro (Tedizolid phosphate), indicated for the treatment of adult acute bacterial skin and skin structure infections (ABSSSI) is now available in the U.S. in once-daily I.V. and oral formulations.

• Ranbaxy Brand Will Be Retained in Most Markets After Sun Pharma Takeover

  8/11/2014

  In the wake of its acquisition of Ranbaxy Laboratories, India's pharmaceutical giant, Sun Pharmaceuticals intends to retain Ranbaxy's brands in most markets. It is however considering phasing out the Ranbaxy name in the U.S. due to its recent regulatory troubles.